Integrating new oral selective oestrogen receptor degraders in the breast cancer treatment.

MLA

Garcia-Fructuoso, Isabel, et al. “Integrating New Oral Selective Oestrogen Receptor Degraders in the Breast Cancer Treatment.” Current Opinion in Oncology, vol. 34, no. 6, Nov. 2022, pp. 635–42. EBSCOhost, https://doi.org/10.1097/CCO.0000000000000892.

APA

Garcia-Fructuoso, I., Gomez-Bravo, R., & Schettini, F. (2022). Integrating new oral selective oestrogen receptor degraders in the breast cancer treatment. Current Opinion in Oncology, 34(6), 635–642. https://doi.org/10.1097/CCO.0000000000000892

Chicago

Garcia-Fructuoso, Isabel, Raquel Gomez-Bravo, and Francesco Schettini. 2022. “Integrating New Oral Selective Oestrogen Receptor Degraders in the Breast Cancer Treatment.” Current Opinion in Oncology 34 (6): 635–42. doi:10.1097/CCO.0000000000000892.